Citalopram
Celexa
Also known as: Inapsine, Droleptan
CredibleMeds Known Risk of TdP (category A) and carries a boxed warning for QT prolongation and torsades. Stacking it on ibogaine's own hERG blockade during the acute window is an additive, potentially lethal QT load.
Severity
Contraindicated
Mechanism
QT-interval prolongation
Protocol Status
Pre-arrival washout (under your prescribing physician)
Restart Delay
Physician discretion
What "Contraindicated" Means
Absolute prohibition without an enforced washout. Treatment cannot proceed safely until the medication has been cleared from the body for the protocol's required interval.
Clinical Action
Do NOT use for ibogaine-induced nausea at any point in the acute window. Choose a non-QT-prolonging antiemetic; if no alternative exists, treat as a physician-level decision with continuous telemetry and a documented QTc.
Where the Washout Happens
Pre-arrival washout (under your prescribing physician)
Discontinuation is completed before arrival, under the patient's own prescribing physician, with the medication-specific washout interval observed before the flood dose.
Pre-Treatment Washout Window
Last dose at least 24 hours before treatment.
Post-Treatment Restart
Restart at physician discretion once acute window closes.
The Pharmacology
Ibogaine and noribogaine block the cardiac hERG (IKr) potassium channel, which lengthens ventricular repolarisation and the QTc interval on a 12-lead EKG. Adding a second QT-prolonging drug compounds the effect and raises the risk of torsades de pointes — a polymorphic ventricular tachycardia that can be fatal. Every patient receives a baseline EKG, electrolyte panel, and continuous cardiac monitoring; medications in this class must be washed out long enough to return QTc into a safe range.
Same Mechanism
Same Severity Tier
Serotonergic activity (serotonin syndrome)
Prozac, Sarafem
Serotonergic activity (serotonin syndrome)
Zoloft
Serotonergic activity (serotonin syndrome)
Paxil, Pexeva
Serotonergic activity (serotonin syndrome)
Luvox
Serotonergic activity (serotonin syndrome)
Trintellix, Brintellix
Serotonergic activity (serotonin syndrome)
Viibryd
Common Questions
Contraindicated. CredibleMeds Known Risk of TdP (category A) and carries a boxed warning for QT prolongation and torsades. Stacking it on ibogaine's own hERG blockade during the acute window is an additive, potentially lethal QT load. Do NOT use for ibogaine-induced nausea at any point in the acute window. Choose a non-QT-prolonging antiemetic; if no alternative exists, treat as a physician-level decision with continuous telemetry and a documented QTc.
Pre-arrival washout (under your prescribing physician). Discontinuation is completed before arrival, under the patient's own prescribing physician, with the medication-specific washout interval observed before the flood dose. Last dose at least 24 hours before treatment.
QT-interval prolongation. Ibogaine and noribogaine block the cardiac hERG (IKr) potassium channel, which lengthens ventricular repolarisation and the QTc interval on a 12-lead EKG. Adding a second QT-prolonging drug compounds the effect and raises the risk of torsades de pointes — a polymorphic ventricular tachycardia that can be fatal. Every patient receives a baseline EKG, electrolyte panel, and continuous cardiac monitoring; medications in this class must be washed out long enough to return QTc into a safe range.
In many cases yes. Our medical team works with your prescribing physician to taper or substitute medications safely before treatment. The right substitution depends on the underlying condition you are treating with Droperidol — contact us for an individual review.
Checking more than one medication? Use the interactive Drug Interaction Checker to screen your full medication list at once.
Browse all 112 medications in the A–Z directory.